These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 31045243)

  • 21. Unexpected Efficacy of a Novel Sodium Channel Modulator in Dravet Syndrome.
    Anderson LL; Hawkins NA; Thompson CH; Kearney JA; George AL
    Sci Rep; 2017 May; 7(1):1682. PubMed ID: 28490751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperthermia-Induced Seizures Enhance Brain Concentrations of the Endocannabinoid-Related Linoleoyl Glycerols in a
    Bahceci D; Anderson LL; Kevin RC; Doohan PT; Arnold JC
    Cannabis Cannabinoid Res; 2023 Jun; 8(3):495-504. PubMed ID: 36269656
    [No Abstract]   [Full Text] [Related]  

  • 23. The central nervous system effects of the partial GABA-Aα2,3 -selective receptor modulator AZD7325 in comparison with lorazepam in healthy males.
    Chen X; Jacobs G; de Kam M; Jaeger J; Lappalainen J; Maruff P; Smith MA; Cross AJ; Cohen A; van Gerven J
    Br J Clin Pharmacol; 2014 Dec; 78(6):1298-314. PubMed ID: 24802722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A clinical study to assess CYP1A2 and CYP3A4 induction by AZD7325, a selective GABA(A) receptor modulator - an in vitro and in vivo comparison.
    Zhou D; Sunzel M; Ribadeneira MD; Smith MA; Desai D; Lin J; Grimm SW
    Br J Clin Pharmacol; 2012 Jul; 74(1):98-108. PubMed ID: 22122233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteomic signature of the Dravet syndrome in the genetic Scn1a-A1783V mouse model.
    Miljanovic N; Hauck SM; van Dijk RM; Di Liberto V; Rezaei A; Potschka H
    Neurobiol Dis; 2021 Sep; 157():105423. PubMed ID: 34144125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-Selective Adeno-Associated Virus-Mediated
    Tanenhaus A; Stowe T; Young A; McLaughlin J; Aeran R; Lin IW; Li J; Hosur R; Chen M; Leedy J; Chou T; Pillay S; Vila MC; Kearney JA; Moorhead M; Belle A; Tagliatela S
    Hum Gene Ther; 2022 Jun; 33(11-12):579-597. PubMed ID: 35435735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpressing wild-type γ2 subunits rescued the seizure phenotype in Gabrg2
    Huang X; Zhou C; Tian M; Kang JQ; Shen W; Verdier K; Pimenta A; MacDonald RL
    Epilepsia; 2017 Aug; 58(8):1451-1461. PubMed ID: 28586508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamic changes of depolarizing GABA in a computational model of epileptogenic brain: Insight for Dravet syndrome.
    Kurbatova P; Wendling F; Kaminska A; Rosati A; Nabbout R; Guerrini R; Dulac O; Pons G; Cornu C; Nony P; ; Chiron C; Benquet P
    Exp Neurol; 2016 Sep; 283(Pt A):57-72. PubMed ID: 27246997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel GABAergic dysfunction in human Dravet syndrome.
    Ruffolo G; Cifelli P; Roseti C; Thom M; van Vliet EA; Limatola C; Aronica E; Palma E
    Epilepsia; 2018 Nov; 59(11):2106-2117. PubMed ID: 30306542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fine mapping and candidate gene analysis of a dravet syndrome modifier locus on mouse chromosome 11.
    Kearney JA; Copeland-Hardin LD; Duarte S; Zachwieja NA; Eckart-Frank IK; Hawkins NA
    Mamm Genome; 2022 Dec; 33(4):565-574. PubMed ID: 35606653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hippocampal deletion of Na
    Stein RE; Kaplan JS; Li J; Catterall WA
    Proc Natl Acad Sci U S A; 2019 Aug; 116(33):16571-16576. PubMed ID: 31346088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epilepsy phenotype associated with a chromosome 2q24.3 deletion involving SCN1A: Migrating partial seizures of infancy or atypical Dravet syndrome?
    Lim BC; Hwang H; Kim H; Chae JH; Choi J; Kim KJ; Hwang YS; Yum MS; Ko TS
    Epilepsy Res; 2015 Jan; 109():34-9. PubMed ID: 25524840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective Na
    Richards KL; Milligan CJ; Richardson RJ; Jancovski N; Grunnet M; Jacobson LH; Undheim EAB; Mobli M; Chow CY; Herzig V; Csoti A; Panyi G; Reid CA; King GF; Petrou S
    Proc Natl Acad Sci U S A; 2018 Aug; 115(34):E8077-E8085. PubMed ID: 30076230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atypical myelinogenesis and reduced axon caliber in the Scn1a variant model of Dravet syndrome: An electron microscopy pilot study of the developing and mature mouse corpus callosum.
    Richards K; Jancovski N; Hanssen E; Connelly A; Petrou S
    Brain Res; 2021 Jan; 1751():147157. PubMed ID: 33069731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purinergic control of hippocampal circuit hyperexcitability in Dravet syndrome.
    Gu F; Hazra A; Aulakh A; Žiburkus J
    Epilepsia; 2014 Feb; 55(2):245-55. PubMed ID: 24417577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of nonsense mutation in GABRG2 with abnormal trafficking of GABAA receptors in severe epilepsy.
    Ishii A; Kanaumi T; Sohda M; Misumi Y; Zhang B; Kakinuma N; Haga Y; Watanabe K; Takeda S; Okada M; Ueno S; Kaneko S; Takashima S; Hirose S
    Epilepsy Res; 2014 Mar; 108(3):420-32. PubMed ID: 24480790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rescuing epileptic and behavioral alterations in a Dravet syndrome mouse model by inhibiting eukaryotic elongation factor 2 kinase (eEF2K).
    Beretta S; Gritti L; Ponzoni L; Scalmani P; Mantegazza M; Sala M; Verpelli C; Sala C
    Mol Autism; 2022 Jan; 13(1):1. PubMed ID: 34980259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Donepezil increases resistance to induced seizures in a mouse model of Dravet syndrome.
    Wong JC; Thelin JT; Escayg A
    Ann Clin Transl Neurol; 2019 Aug; 6(8):1566-1571. PubMed ID: 31402621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Developmental alterations in firing properties of hippocampal CA1 inhibitory and excitatory neurons in a mouse model of Dravet syndrome.
    Almog Y; Fadila S; Brusel M; Mavashov A; Anderson K; Rubinstein M
    Neurobiol Dis; 2021 Jan; 148():105209. PubMed ID: 33271326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulation of Haploinsufficient Gene Expression in the Brain by Targeting a Long Non-coding RNA Improves Seizure Phenotype in a Model of Dravet Syndrome.
    Hsiao J; Yuan TY; Tsai MS; Lu CY; Lin YC; Lee ML; Lin SW; Chang FC; Liu Pimentel H; Olive C; Coito C; Shen G; Young M; Thorne T; Lawrence M; Magistri M; Faghihi MA; Khorkova O; Wahlestedt C
    EBioMedicine; 2016 Jul; 9():257-277. PubMed ID: 27333023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.